Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency
The primary information has been curated from the literature and consists of the following major fields namely: (i) PMID, (ii) the peptide sequence, (iii) the name of peptide, (iv) the length of peptide, (v) N-terminal modification, (vi) C-terminal modification (vii) configuration (linear or cyclic) (viii) chirality of the amino acids, (ix) chemical modification, (x) origin of the peptide, (xi) biological activity of the peptide, (xii) half-life, (xiii) assay types, (xiv) sample on which the half-life was tested and (xv) Patent ID
Colored contact lenses are popular, for their convenience and versatility in changing one's appearance for occasions or simply for fun
Vitamin C in Mouse and Human Red Blood Cells: An HPLC Assay
The European Union (EU) Joint Programme-Neurodegenerative Disease Research (JPND) states that by the year 2030, a quarter (25%) of the European population will be over age 65, a significant increase over the current 16% [1]